Detection of SNCA and FBN1 Methylation in the Stool as a Biomarker for Colorectal Cancer

Aim. We examined the methylation status of SNCA and FBN1 genes in patients' paired tissue and stool samples for detection of colorectal cancer (CRC). Patients and Methods. 89 DNA tissue samples (normal/cancer) and corresponding stool samples were analyzed in our study. In addition, 30 stool samples were collected as healthy controls. Results. The methylation level of those samples was measured by methylation-specific polymerase chain reaction (MSP). The result shows that compared with the paired controls, both SNCA and FBN1 were significantly hypermethylated in CRC patients in tissue samples (P < 0.001). In the stool samples, hypermethylated SNCA and FBN1 were detected to be significantly higher than that in normal stool samples (P < 0.001). The combined sensitivity of at least one positive among the two markers in stool samples was 84.3%, with a specificity of 93.3%. In addition, our experiment suggested that the positive rates of SNCA and FBN1 in Dukes A stage were significantly higher than that of FOBT (P = 0.039; P = 0.006, resp.). Conclusion. We concluded that methylation testing of SNCA and FBN1 genes in stool sample may offer a good alternative in a simple, promising, and noninvasive detection of colorectal cancer.

[1]  L. Myeroff,et al.  Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. , 2005, Journal of the National Cancer Institute.

[2]  C. Lengauer.  Cancer. An unstable liaison. , 2003, Science.

[3]  H. Zhang,et al.  Detection of Hypermethylated Spastic Paraplegia-20 in Stool Samples of Patients with Colorectal Cancer , 2013, International journal of medical sciences.

[4]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[5]  B. Achinstein,et al.  Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.

[6]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Mark P Purdue,et al.  Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. , 2012, The New England journal of medicine.

[8]  A. Gazdar,et al.  DNA methylation based biomarkers in non-invasive cancer screening. , 2010, Current molecular medicine.

[9]  F. Chan,et al.  Detection of epigenetic changes in fecal DNA as a molecular screening test for colorectal cancer: a feasibility study. , 2004, Clinical chemistry.

[10]  S. Baylin.  Mechanisms underlying epigenetically mediated gene silencing in cancer. , 2002, Seminars in cancer biology.

[11]  Qi Guo,et al.  Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer , 2014, Medical Oncology.

[12]  S. Ciatto,et al.  Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. , 1996, British Journal of Cancer.

[13]  R. Lamerz,et al.  Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[15]  G. Meijer,et al.  Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection , 2012, Cellular Oncology.

[16]  Qi Guo,et al.  Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients , 2013, Medical Oncology.

[17]  M. Washington,et al.  Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[19]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[20]  S. J. Mills,et al.  Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  J. Lutterbaugh,et al.  Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. , 2001, Cancer research.

[22]  Á. Lanas,et al.  Vorsorge des kolorektalen Karzinoms: Koloskopie oder immunologischer Stuhltest , 2013, Zeitschrift für Gastroenterologie.

[23]  R. Lothe,et al.  Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas , 2011, Molecular Cancer.

[24]  W. Leung,et al.  Increasing incidence of colorectal cancer in Asia: implications for screening. , 2005, The Lancet. Oncology.

[25]  C. Ostwald,et al.  Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. , 2009, International journal of oncology.

[26]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[27]  W. Grady,et al.  Genomic and epigenetic instability in colorectal cancer pathogenesis. , 2008, Gastroenterology.

[28]  A. Adrain,et al.  A comparison of fecal occult-blood tests for colorectal-cancer screening. , 1996, The New England journal of medicine.

[29]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[30]  Xiao-tong Hu,et al.  Advances in epigenetic biomarker research in colorectal cancer. , 2014, World journal of gastroenterology.

[31]  Christoph Lengauer,et al.  An Unstable Liaison , 2003, Science.